Non-coding RNAs: the new central dogma of cancer biology

PE Saw, X Xu, J Chen, EW Song - Science China Life Sciences, 2021 - Springer
The central dogma of molecular biology states that the functions of RNA revolve around
protein translation. Until the last decade, most researches were geared towards …

Metabolic reprogramming in glioma

M Strickland, EA Stoll - Frontiers in cell and developmental biology, 2017 - frontiersin.org
Many cancers have long been thought to primarily metabolize glucose for energy production—
a phenomenon known as the Warburg Effect, after the classic studies of Otto Warburg in the …

[HTML][HTML] AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo

B Faubert, G Boily, S Izreig, T Griss, B Samborska… - Cell metabolism, 2013 - cell.com
AMPK is a metabolic sensor that helps maintain cellular energy homeostasis. Despite
evidence linking AMPK with tumor suppressor functions, the role of AMPK in tumorigenesis …

The microcosmos of cancer

A Lujambio, SW Lowe - Nature, 2012 - nature.com
The discovery of microRNAs (miRNAs) almost two decades ago established a new
paradigm of gene regulation. During the past ten years these tiny non-coding RNAs have …

Ribosomal protein S6: a potential therapeutic target against cancer?

YW Yi, KS You, JS Park, SG Lee, YS Seong - International journal of …, 2021 - mdpi.com
Ribosomal protein S6 (RPS6) is a component of the 40S small ribosomal subunit and
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …

Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone

JM Lemée, A Clavreul, P Menei - Neuro-oncology, 2015 - academic.oup.com
Glioblastoma (GB) is the most frequent and aggressive primary tumor of the central nervous
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …

Recent advances in the molecular understanding of glioblastoma

FE Bleeker, RJ Molenaar, S Leenstra - Journal of neuro-oncology, 2012 - Springer
Glioblastoma is the most common and most aggressive primary brain tumor. Despite
maximum treatment, patients only have a median survival time of 15 months, because of the …

Selective release of microRNA species from normal and malignant mammary epithelial cells

L Pigati, SCS Yaddanapudi, R Iyengar, DJ Kim… - PloS one, 2010 - journals.plos.org
MicroRNAs (miRNAs) in body fluids are candidate diagnostics for a variety of conditions and
diseases, including breast cancer. One premise for using extracellular miRNAs to diagnose …

The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator

B Faubert, EE Vincent, MC Poffenberger, RG Jones - Cancer letters, 2015 - Elsevier
The AMP-activated protein kinase (AMPK) is a central regulator of cellular metabolism and
energy homeostasis in mammalian tissues. Pertinent to cancer biology is the fact that AMPK …

Targeting adaptive glioblastoma: an overview of proliferation and invasion

Q Xie, S Mittal, ME Berens - Neuro-oncology, 2014 - academic.oup.com
Glioblastoma is one of the most devastating cancers, in which tumor cell infiltration into
surrounding normal brain tissue confounds clinical management. This review describes …